The membrane-anchored myelin enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) was discovered in the early 1960s and has since then troubled scientists with its peculiar catalytic activity and high expression levels in the central nervous system. Despite decades of research, the actual physiological relevance of CNPase has only recently begun to unravel. In addition to a role in myelination, CNPase is also involved in local adenosine production in traumatic brain injury and possibly has a regulatory function in mitochondrial membrane permeabilization. Although research focusing on the CNPase phosphodiesterase activity has been helpful, several open questions concerning the protein function in vivo remain unanswered. This review is focused on past research on CNPase, especially in the fields of structural biology and enzymology, and outlines the current understanding regarding the biochemical and physiological signifi cance of CNPase, providing ideas and directions for future research.
Introduction
Myelin is a specialized multilamellar structure, which is wrapped around neuronal axons by oligodendrocytes in the central nervous system (CNS) and by Schwann cells in the peripheral nervous system (PNS). The membrane sheets of myelin are densely packed, resulting in the extrusion of cytosolic elements and in the formation of a lipid-rich, insulating sheath that enables the acceleration of nerve impulses. A mature myelin sheath can be morphologically divided into compact and non-compact myelin, of which the latter has a higher cytosolic content and further contains several subcompartments, such as the abaxonal and adaxonal layers, as well as the paranodal loops [1, 2] .
Myelin contains a set of unique proteins that generally display strict localization to either compact or non-compact myelin, which is thought to be at least partially driven by size exclusion [3, 4] . The myelin environment being low in aqueous content and harboring negatively charged, tightly packed membrane interfaces, myelin proteins typically exhibit attributes such as strong hydrophobicity, peripheral membrane association, transmembrane domains, and a high positive net charge, as well as intrinsic disorder [5] .
Several myelin proteins have delicately regulated expression levels and functions. Past research using cell culture and animal models have outlined the importance of various proteins in demyelination -a situation where myelin undergoes morphological changes and loss [6] .
much less -merely 0.5% of total PNS myelin protein [4, 14, 15] .
Two isoforms of CNPase have been identified, which originate from two alternative promoters and 3′,5′-cAMPregulated splicing of one of the mRNA variants produced from the CNP1 gene, in humans encoded in chromosome 17 [16] [17] [18] [19] [20] [21] . The difference between the variants is the presence of a 20-amino-acid N-terminal mitochondrial targeting sequence (MTS) in the 48-kDa isoform II, which is removed after mitochondrial import to produce a truncated variant that corresponds to the cytosolic isoform I of 400 amino-acids [20, 22, 23] . In addition to its high expression levels, CNPase has been characterized as a protein of extreme longevity, along with several other myelin proteins [24] .
CNPase is composed of two folded domains and a C-terminal extension, which has been characterized to be disordered in solution as a peptide ( Fig. 2 ) [25] [26] [27] [28] . The C-terminal domain harbors the catalytic phosphodiesterase activity and is, both reaction-and structure-wise, a member of the 2H phosphoesterase superfamily, harboring a double
His-X-Thr-X (X denotes a hydrophobic residue) motif typical for the family [28, 29] . With the exception of platypus,
CNPase is ubiquitously expressed in vertebrates, as well as in some invertebrates. However, there is some domain variation between species; the conservation of CNPase has recently been outlined via bioinformatics [30] . Compared to the catalytic phosphodiesterase domain, the N-terminal domain remains poorly characterized to date. Although its in vivo function remains to be determined, it shares some homology with T4 bacteriophage polynucleotide kinase (PNK). This PNK-like domain contains a conserved P-loop structure, which suggests ATP/GTP binding [25] . The function of CNPase has been a mystery ever since its discovery. After decades of research, its putative functions at the molecular level have only recently begun to be unveiled. Advances in structural biology, as well as the discovery of endogenous 2′,3′-cNMPs, have shed some light on its possible functions [31, 32] . These matters, as well as the signifi cance of the molecular motifs in CNPase, are addressed in more detail below.
CNPase in Health & Disease
The importance of CNPase at the translational level has been investigated through knockout studies in mice. The absence of CNPase causes premature death through axonal swelling, while maintaining a myelin morphology very similar to wild-type animals. The behavioral phenotype manifests as a loss of motor abilities through muscle weakness and finally death, typically at the age of 6 to 12 months [33] . [34, 35] . An interesting trait is also the accumulation of (poly)ubiquitinated and partially degraded CNPase in myelin lipid rafts, which might contribute to the changes in axonal and myelin morphology upon aging [36] .
Cell culture studies have demonstrated the importance of CNPase at the early stages of myelination. CNPase is essential for oligodendrocyte process outgrowth via its membrane association, as well as its ability to interact with the cytoskeleton (see below). CNPase is essential in oligodendrocyte process formation and branching, and a C-terminally truncated variant of CNPase, as well as a mutant unable to membrane-associate, affects these processes [37] . The true physiological relevance of this, however, is unclear, since myelination in CNPase-defi cient mice seems to proceed normally, and the neuronal aberrations appear months later along with the behavioral phenotype [33] . This suggests that in the absence of CNPase, its possible physiological function in process outgrowth may be complemented by currently unknown factors, and the role of CNPase after active myelination could be related to axonal maintenance [33] .
In MS, demyelination occurs in the brain and spinal cord, resulting in a wide array of neurological symptoms.
Together with several other CNS myelin proteins, CNPase is an auto-antigen in MS -a chronic autoimmune disease [11, [38] [39] [40] . Changes in the expression levels of
CNPase have been linked to Alzheimer's disease, Down's syndrome, and catatonia-depression syndrome [41, 42] .
CNP1 has also been identifi ed as a susceptibility gene in schizophrenia, although the described findings appear to have a somewhat specific geographical localization and have been challenged by other studies. A single-nucleotide polymorphism that does not alter the amino-acid sequence of CNPase, but rather decreases its expression levels, has been suggested to play a role in schizophrenia [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] .
Structure and Function of CNPase
The Phosphodiesterase Domain Harbors Catalytic
Activity
The catalytic phosphodiesterase domain makes up the C-terminal half of the CNPase polypeptide. Truncation experiments demonstrated that truncations after amino acid 164 in recombinant rat CNPase result in a loss of phosphodiesterase activity [28] . The catalytic domain is composed of ~240 amino acids, is highly conserved in mammals, and is present in all identified CNPases throughout different organisms [30] .
The catalytic domain of CNPase catalyzes the hydrolysis of 2′,3′-cNMPs to 2′-NMPs -an activity that was for long considered to be peculiar. Apart from some intermediate states formed in tRNA splicing, endogenous 2′,3′-cNMPs were not observed until recently. Verrier et al. discovered a metabolic pathway present in astrocytes, microglia, and most notably, in oligodendrocytes [31, 32, 55] .
The discovery of this pathway linked CNPase to the local production of the neuroprotectant adenosine,
where CNPase rapidly depletes adenosine 2′,3′-cyclic monophosphate (2′,3′-cAMP), a compound indentifi ed as a mitochondrial toxin that presumably forms as a by-product of mRNA transphosphorylation [56] [57] [58] [59] . The accumulation of 2′,3′-cAMP was found in very young CNPase-deficient mice used to study traumatic brain injury, which developed post-traumatic axonal degeneration similar to that of older CNPase-deficient mice that did not experience brain trauma [31] [32] [33] . This further supports the hypothesis of CNPase playing a role in axonal maintenance after myelination, possibly through neuroprotection arising from a major contribution to the hydrolysis of 2′,3′-cAMP produced within myelinated axons [32, 33, 56] .
In addition, CNPase was earlier thought to be involved in RNA metabolism in a manner similar to several other 2H phosphoesterases [60] . This was supported by CNPase being able to bind RNA molecules and having phosphodiesterase activity towards oligonucleotides with terminal 2′,3′-cyclic monophosphates, which, prior to the discovery of the 2′,3′-cAMP pathway, were the only known endogenous molecules containing such a cyclic phosphodiester linkage [61] [62] [63] . Indicating enzymatic functionality in vivo,
CNPase is capable of rescuing yeast with the cyclic phosphodiesterase (CPDase) domain inactivated from the multifunctional tRNA ligase Trl1p, an essential protein for tRNA maturation [64] .
The enzymatic phosphodiesterase activity of CNPase is one of the best characterized features of the protein. The reaction itself was discovered together with the enzyme in the early 1960s, but the catalytically essential residues were identified 40 years later via mutagenesis [12, 28] .
Prior to that, CNPase had already been shown to have substrate stereoselectivity, using nucleoside 2′,3′-cyclic monophosphorothioate analogs [65] .
Although the domain structure of CNPase had already been known for some time, the C-terminal catalytic domain could be described as a member of the 2H phosphoesterase superfamily only after its initial structure determination in 2003 by NMR spectroscopy [29] . Sakamoto et al. postulated a putative binding mode and active site for the enzyme, when they solved the fi rst CNPase crystal structure [66] . A simple mechanistic reaction scheme for CNPase could be then described. Both the NMR and the crystal structure showed the catalytic domain to share high structural homology with 2H phosphoesterases, with a pseudo 2-fold symmetric double His-X-Thr-X motif in the active site (Fig. 3A, B ) [28, 29, 66] .
Since its initial structural characterization, CNPase has been extensively studied, and a detailed mechanistic reaction scheme has recently been described, based on protein-ligand complex structures (Fig. 3C, D ) [30, 67] . In brief, the reaction in mouse CNPase begins with a His309- [69] [70] [71] .
One of the most notable differences between CNPase and other 2H phosphoesterases is the presence of an additional α-helix in the proximity of the active site cleft (helix α7, Fig. 3 ), which apparently is a key factor in determining the substrate stereoselectivity of CNPase. The loop structure before helix α7 is dynamic, and its conformation is linked to the catalytic cycle of the enzyme [30, 67] . The only known protein to share this helix with CNPase is the regeneration-induced CNPase homolog, RICH. Both sequence-and structure-wise, the C-terminal domain of RICH is the closest homolog to the catalytic domain of CNPase, and it might also harbor functional similarity, as it has been shown in NMR titration experiments to bind 3′-AMP, an inhibitor of CNPase [72] .
The PNK-like Domain May Have Several Functions
Our recent bioinformatics study [30] demonstrated that the PNK-like domain is present in all CNPases throughout vertebrates, except goldfi sh, zebrafi sh, and Japanese rice fi sh. In these three species, the domain has been replaced by a glutamate-rich N-terminal acidic domain. In addition to the PNK-like domain, the acidic domain is also present in salmon and Nile tilapia. On the other hand, the PNK-like domain is present in the six so-far discovered invertebrate
CNPase homologs [30] .
Compared to the phosphodiesterase domain, the PNK-like domain remains structurally poorly characterized, although models using solution small-angle X-ray scattering and homology modeling based on T4 PNK have been recently described [30, 62] . Despite the low overall sequence homology to T4 PNK, a highly conserved P-loop structure, which is usually found in PNKs, is also present in the CNPase PNK-like domain [25, 73] . P-loops (phosphate binding loops), or Walker A motifs, are usually ATP-binding sites present in many nucleotide-binding proteins [74, 75] . CNPase has been found to bind ATP and GTP as well as to have hydrolytic activity towards them, suggesting putative PNK .
The PNK-like domain interacts with RNA, calmodulin (CaM), and cytoskeletal elements [37, 61, 62, 67, [76] [77] [78] . Interaction with RNA is a property of many 2H phosphoesterases, and CNPase, indeed, binds RNA and also appears to have some selectivity towards certain RNA sequences [61] .
The presence of the catalytic domain alone is enough to mediate RNA binding, but the PNK-like domain was later shown to enhance the interaction [61, 67] . Independently and HIV-1 [61, 79, 80] . The interaction with RNA also provides a tempting idea to link CNPase to RNA metabolism.
RNA processing is a rather typical role amongst other 2H phosphoesterases and, combined with the possible PNK and phosphodiesterase activities outlined above, it has been discussed for years whether CNPase might play a role in RNA metabolism [60] . In addition, the fi ndings that CNPase also interacts with filamentous actin and tubulin, as well as its ability to promote microtubule formation, make CNPase a possible candidate in RNA trafficking [37, 61, 62, 78, 81] . In oligodendrocytes, it is known that the mRNAs of several proteins are translocated to various subcellular compartments prior to translation, and CNPase might function in this context [61, 82] . It can be speculated that the translocation of compact myelin protein mRNAs for localized translation could be one of the driving forces that result in oligodendrocytic process formation during early myelination. The fact that CNPase binds to microtubules, however, also gives it a possible structural role, taking into account its membrane association. It also prefers to bind heterodimers of α-and β-tubulin and, thus, induces microtubule formation [37, 77, 78] .
CaM has recently been shown to bind directly to the PNK-like domain with a dissociation constant of 100 nmol/L [62, 76, 83] . The interaction is dependent on Ca 2+ , and the proposed interaction site is located in the vicinity of the P-loop [62] . While the phosphodiesterase domain does not bind CaM, and its activity is unaffected by the presence of CaM, it remains to be determined whether the binding of CaM has an impact on ATP/GTP binding and/or possible PNK activity. Interestingly, recombinant full-length CNPase only binds CaM in vitro, if the very C-terminal extension (the membrane anchor) has been deleted [62] .
The C-terminal Extension Mediates Peripheral

Membrane Association
The C-terminal tail extension of 13 residues has been characterized via circular dichroism spectroscopy to be unfolded as a peptide in membrane-mimicking conditions, although a challenging report was published earlier, and post-translational modifications might contribute to its conformation in the context of the full-length protein [27, 84] .
While the tail has been shown to be required for tubulin interactions and polymerization, as well as to abolish the binding of CaM to the PNK-like domain in vitro, the tail harbors a reactive Cys residue that undergoes fatty acylation in vivo [37, 62, 85, 86] . This modification anchors
CNPase to the membrane of non-compact myelin and, hence, makes CNPase a peripheral membrane protein.
As mentioned above, removal of the tail alters the process formation of cultured oligodendrocytes. Furthermore, mutating the modified Cys residue to Ala produces the same result, indicating the importance of CNPase membrane association in process formation [37, 81, 87, 88] .
The C-terminal tail itself is likely to extend from between the two folded domains, and it resides close to the phosphodiesterase domain active site [67] . Hence, when CNPase is membrane-anchored, the active site of the phosphodiesterase domain lies close to the membrane surface and possibly faces the membrane.
The tail itself does not influence the catalytic activity of the phosphodiesterase domain, as activity assays have demonstrated that the presence or absence of the C-terminal extension does not signifi cantly affect the kinetic constants [89] . However, especially for possible bulkier substrates, such as RNA, the effect of the tail and the proximity of the membrane remains to be determined.
Isoform II Is the Mitochondrial Variant of CNPase in Non-myelinating Glia
Only a few studies have been published on CNPase isoform II, which, as opposed to isoform I, is expressed only in minor amounts in myelinating glia. The abundance of isoform II is higher in the adult liver and embryonic brain, where isoform I is practically absent. The MTS in CNPase isoform II is responsible for mitochondrial import, which is regulated via phosphorylation by protein kinase C [22] . The mitochondrial, fully-processed isoform II does not drive morphological differentiation in cell cultures as isoform I does in oligodendrocytes [22, 37] . Instead, CNPase is localized to the intermembrane space, where it resides as a peripheral membrane protein at the inner mitochondrial membrane [22] . The function of CNPase in mitochondria is not thoroughly understood, but CNPase, together with 2′,3′-cAMP, has been suggested to modulate the mitochondrial permeability transition, a proapoptotic event, in which Ca 2+ is released from the mitochondrial matrix to the intermembrane space and cytoplasm [59] .
This again raises questions regarding the significance of the CNPase-CaM interaction, as it is rather enticing to speculate an interconnection between membrane-bound CNPase, free 2′,3′-cAMP, and Ca 2+ , as well as the Ca 2+ -sensor CaM and mitochondrial membrane permeability.
Perhaps mitochondrial CNPase functions as a protective
enzyme that is involved in toxic 2′,3′-cAMP hydrolysis in a CaM-regulated manner, which then impacts pro-apoptotic membrane permeability.
Summary and Open Questions
The myelin enzyme CNPase was discovered over 50 years ago, and its strong expression profile and peculiar CNPase is possibly one player of many in the axonal support systems provided by myelinating glia [90] .
Another important consideration is the function of 
